UNICHEM LABORATORIES LTD. - 506690 - Disclosure Of Related Party Transactions On Consolidated Basis For Half Year Ended March 31, 2020
Disclosure of Related Party Transactions on Consolidated basis for half year ended March 31, 202009-07-2020
UNICHEM LABORATORIES LTD. - 506690 - Disclosure Of Related Party Transactions On Consolidated Basis For Half Year Ended March 31, 2020
Disclosure of Related Party Transactions on Consolidated basis for half year ended March 31, 2020Unichem Laboratories gets USFDA nod to market muscle spasm tablets
The company has received abbreviated new drug application (ANDA) approval to market its Cyclobenzaprine Hydrochloride tablets USP 5 mg, 7.5 mg and 10 mg from the United States Food and Drug Administration (USFDA), Unichem Labs said in a filing to the BSE.UNICHEM LABORATORIES LTD. - 506690 - ANDA Approval From USFDA For Unichem'S Cyclobenzaprine Hydrochloride Tablets.
ANDA Approval from USFDA for Unichem'S Cyclobenzaprine Hydrochloride TabletsUNICHEM LABORATORIES LTD. - 506690 - Closure of Trading Window
Pursuant to the Company's Code of Conduct to Regulate, Conduct, Monitor and Report Trading by Insiders, formulated and adopted under the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 duly amended, the Trading Window for dealing in shares of the Company will be closed immediately from July 1, 2020 for Designated Persons, Insiders and their Immediate Relatives and shall open 48 (forty eight) hours after the financial results for the quarter ended June 30, 2020 are made public.Unichem, Lupin recall high blood pressure drugs from US over quality issues
The specified batch, which is being recalled, has been manufactured at Unichem's Goa-based facilityUNICHEM LABORATORIES LTD. - 506690 - Fixes Book Closure for Dividend & AGM
Unichem Laboratories Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from August 24, 2020 to August 29, 2020 (both days inclusive) for the purpose of Payment of Dividend & 57th Annual General Meeting (AGM) of the Company to be held on August 29, 2020.The Dividend, if declared at the 57th AGM, shall be paid to the shareholders on September 04, 2020.UNICHEM LABORATORIES LTD. - 506690 - Board recommends Dividend (AGM on August 29, 2020)
Unichem Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 19, 2020, inter alia, has recommended Dividend of Rs. 4/- (200%) per equity share of Rs. 2/- each, for the year ended March 31, 2020, subject to approval of shareholders at the ensuing Annual General Meeting.UNICHEM LABORATORIES LTD. - 506690 - Results For Quarter And Year Ended 31.3.2020 And Recommendation Of Dividend
Results for the quarter and year ended 31.3.2020 and recommendation of dividend